Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2021
BioInvent and MSD enter a clinical-trial collaboration for BI-1808 and KEYTRUDA
BioInvent announced a second clinical-trial collaboration and supply agreement with MSD to evaluate BioInvent’s BI-1808 with MSD’s KEYTRUDA in a Phase 1/2a trial involving patients with lung and ovarian cancer.
2019
Pfizer selects a second target in collaboration with BioInvent
BioInvent announced that Pfizer selected a second target under their cancer immunotherapy research collaboration and license agreement, triggering a $300,000 payment from Pfizer to BioInvent.